Prudential Financial’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-102,708
Closed -$5.43M 2532
2020
Q3
$5.43M Buy
102,708
+6,366
+7% +$393K 0.01% 899
2020
Q2
$5.9M Buy
96,342
+9,540
+11% +$552K 0.01% 896
2020
Q1
$4.91M Sell
86,802
-15,808
-15% -$901K 0.01% 923
2019
Q4
$5.84M Buy
102,610
+6,694
+7% +$355K 0.01% 1067
2019
Q3
$5.13M Buy
95,916
+29,849
+45% +$1.74M 0.01% 1101
2019
Q2
$3.94M Sell
66,067
-3,770
-5% -$237K 0.01% 1265
2019
Q1
$4.35M Sell
69,837
-1,661
-2% -$110K 0.01% 1197
2018
Q4
$4.33M Sell
71,498
-1,970
-3% -$118K 0.01% 1154
2018
Q3
$4.3M Sell
73,468
-8,176
-10% -$417K 0.01% 1244
2018
Q2
$3.66M Buy
81,644
+8,452
+12% +$364K 0.01% 1348
2018
Q1
$3.25M Sell
73,192
-1,996
-3% -$83.8K ﹤0.01% 1341
2017
Q4
$3.26M Buy
75,188
+7,821
+12% +$352K ﹤0.01% 1341
2017
Q3
$3.13M Buy
67,367
+1,620
+2% +$77.6K ﹤0.01% 1354
2017
Q2
$3.25M Buy
65,747
+328
+0.5% +$17.2K ﹤0.01% 1327
2017
Q1
$3.58M Sell
65,419
-570
-0.9% -$30.2K 0.01% 1281
2016
Q4
$3.67M Buy
65,989
+6,049
+10% +$291K 0.01% 1245
2016
Q3
$2.74M Buy
59,940
+4,640
+8% +$186K ﹤0.01% 1356
2016
Q2
$2.21M Buy
55,300
+26,534
+92% +$972K ﹤0.01% 1514
2016
Q1
$1M Buy
28,766
+3,966
+16% +$146K ﹤0.01% 1806
2015
Q4
$1.07M Sell
24,800
-6,300
-20% -$316K ﹤0.01% 1767
2015
Q3
$1.35M Buy
31,100
+21,400
+221% +$1.15M ﹤0.01% 1647
2015
Q2
$501K Buy
+9,700
New +$414K ﹤0.01% 1957

Other funds holding BSTC

Prudential Financial's BSTC Position: Q4 2020 in Review

Prudential Financial sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 102,708 shares — an estimated $5.43M sold.

Prudential Financial first reported a position in BSTC in Q2 2015 and held it in 22 quarters. The position peaked at $5.9M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Prudential Financial reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Prudential Financial sold 102,708 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $5.43M.
  • Prudential Financial first reported a position in BioSpecifics Technologies Corp. in Q2 2015 and held it in 22 quarters.
  • Prudential Financial's BioSpecifics Technologies Corp. position peaked at $5.9M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Prudential Financial's 13F filing for Q4 2020, filed 16 Feb 2021.